Chugai Pharmabody Research is rated 3 out of 5 in the category innovation beyond imagination. Read and write reviews about Chugai Pharmabody Research. In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.
Address
3 Biopolis Dr #07 -11 to 16
Company size
51-200 employees
Headquarters
Singapore, Singapore